XML 32 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2017
Operating Activities:      
Net income (loss) $ 7,592 $ (4,457) $ 3,926
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 7,312 6,431 5,555
Stock-based compensation 5,077 4,807 3,472
Payment of contingent consideration obligations in excess of acquisition-date value (2,041)    
Contingent consideration (gain) expense (161) 675 (127)
Acquired in-process research and development 890 7,888  
Deferred taxes [1] (1,088) (2,277) 1,000
Gains on strategic investments (7) (177) (43)
Provision for bad debts 160 85 208
Impairment losses on intangible assets 259   427
Property and equipment disposal loss (10)   6
Unrealized foreign exchange (gain) loss   (148) 474
Other, net 1 45  
Change in operating assets and liabilities      
Accounts receivable and contract asset [1] (1,630) (1,773) (528)
Inventories (543) (513) 97
Prepaids and other (2,131) (1,584) (599)
Accounts payable (765) 155 1,101
Accrued liabilities (2,187) 5,086 (733)
Deferred revenue [1] (3,512) 20,651 (124)
Income taxes [1] 822 (842) (59)
Net cash provided by operating activities 8,038 34,052 14,053
Investing Activities:      
Purchases of property and equipment (5,998) (9,092) (6,432)
Cash proceeds from sale of property and equipment 10    
Purchases of available-for-sale securities (44,973) (81,536) (73,671)
Sales and maturities of available-for-sale securities 61,458 71,951 63,871
Acquisition of in-process research and development (Note 10) (750) (5,000)  
Cash received from strategic investments 7 177 43
Net cash used in investing activities 9,754 (23,500) (16,189)
Financing Activities:      
Issuance of common stock 723 2,089 444
Payments for taxes related to net share settlement of equity awards (2,688) (4,557) (2,156)
Payment of contingent consideration (9,064) (925)  
Payment of deferred financing costs     (96)
Repurchase of common stock     (4,702)
Net cash used in financing activities (11,029) (3,393) (6,510)
Effect of exchange rate changes on cash (70) (25) 193
Net change in cash and cash equivalents 6,693 7,134 (8,453)
Cash and Cash Equivalents:      
Beginning of year 23,668 16,534 24,987
End of year 30,361 23,668 16,534
Supplemental Information:      
Cash paid for income taxes 193 914 2,114
Noncash financing and investing activities:      
Acquisition of property and equipment on account, net of refundable credits in other current assets 202 632 $ 109
Acquisition of property and equipment in long-term deferred rent   1,200  
Acquisition of in process research and development in other long-term liabilities 140 2,888  
Accrual of employee taxes on common stock exercises $ 104 $ 130  
[1] Amounts presented are net of impact from adoption of ASC Topic 606.